share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mauro David J

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mauro David J

Recursion Pharmaceuticals | 4:持股變動聲明-高管 Mauro David J
美股SEC公告 ·  08/19 19:13

Moomoo AI 已提取核心訊息

Recursion Pharmaceuticals' Chief Medical Officer, Mauro David J, completed a sale of 14,146 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total sale value of $94,636.74. Following the sale, Mauro David J directly holds 229,616 shares in the company. The sale was executed to cover the payment of exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
Recursion Pharmaceuticals' Chief Medical Officer, Mauro David J, completed a sale of 14,146 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total sale value of $94,636.74. Following the sale, Mauro David J directly holds 229,616 shares in the company. The sale was executed to cover the payment of exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
Recursion Pharmaceuticals的首席醫學官Mauro David J於2024年8月15日完成了對公司A類普通股的14,146股的銷售。交易價格爲每股6.69美元,總售價爲94636.74美元。銷售後,Mauro David J直接持有公司的229,616股。此次銷售是爲了通過交付或扣除證券來支付行權價格或稅款負債,這是交易代碼'F'所表示的。
Recursion Pharmaceuticals的首席醫學官Mauro David J於2024年8月15日完成了對公司A類普通股的14,146股的銷售。交易價格爲每股6.69美元,總售價爲94636.74美元。銷售後,Mauro David J直接持有公司的229,616股。此次銷售是爲了通過交付或扣除證券來支付行權價格或稅款負債,這是交易代碼'F'所表示的。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息